Resitu: minimally invasive surgical technology

Medlim bootcamp

Resitu Medical has been selected as 1 of 16 companies from 68 applicants for the MedLim Matchmaking & Fast Track Acceleration Program. The program is offered to promising startups that develop breakthrough, innovative MedTech products and services in the Cardiovascular, Neurological, Spine & Medical Surgical domains.

Published 2022-04-22

A collaboration with MedLim and the expertise partners is unique as they will provide support with world class experts in the field of business, medical device development, regulatory, IP and financing. A limited selection of startups/scaleups will have a unique opportunity to work closely with these experts in the Limburg region (NL) and to benefit from quick access and the know-how of the MedLim partners (Medtronic & LIOF, and expert centers of Brightlands Maastricht Health Campus & Medace) supported by the imec.istart team.


Resitu Medical AB
Rapsgatan 7B
Uppsala, Sweden

Resitu Medical AB is a Swedish Medical Device company founded in 2019. The company is developing instruments enabling safe removal of intact tissues by a revolutionary technology. The solution has the potential to create a paradigm shift in the management of breast cancer. The portfolio of instruments will speed up the process of cancer management using a minimally invasive approach and facilitating the way radiologists and surgeons work.

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively.